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Abstract
Background: Although CRISPR/Cas enables one-step gene cassette knock-in, assembling targeting vectors
containing long homology arms is a laborious process for high-throughput knock-in. We recently developed the
CRISPR/Cas-based precise integration into the target chromosome (PITCh) system for a gene cassette knock-in
without long homology arms mediated by microhomology-mediated end-joining.
Results: Here, we identified exonuclease 1 (Exo1) as an enhancer for PITCh in human cells. By combining the Exo1
and PITCh-directed donor vectors, we achieved convenient one-step knock-in of gene cassettes and floxed allele
both in human cells and mouse zygotes.
Conclusions: Our results provide a technical platform for high-throughput knock-in.
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Background
Knock-in mice carrying functional gene cassettes have
provided invaluable opportunities for in vivo func-
tional analysis of genes and cells in mammalian or-
ganisms [1]. Despite the recent rapid displacement of
conventional gene-targeting technology in embryonic
stem cells [2] by CRISPR/Cas-mediated genome edit-
ing [3–5] in mouse zygotes [6–10], the cumbersome
task of targeting vector construction containing a
gene cassette flanked by long homology arms (generally
longer than several kilobases for each) corresponding to
every target loci remains unchanged [11, 12]. This limits
the feasibility of CRISPR/Cas-mediated, large-scale, high-
throughput generation [13, 14] of knock-in mice carrying
functional gene cassettes and limits the convenience and
availability of the CRISPR/Cas system for mammalian or-
ganisms [1, 15].
The homologous recombination (HR)-mediated repair
of DNA double-strand breaks (DSBs) induced by CRISPR/
Cas has been used to knock-in the gene cassettes in en-
dogenous target genomic loci in mouse zygotes [6, 8, 10].
However, the DSBs are primarily repaired through nonho-
mologous end joining (NHEJ) in mammalian cells, and
thus the frequency of HR-mediated repair is intrinsically
low [16]. The efficiencies of HR-mediated gene cassette
knock-in in mice are around 10–20%, much less than that
(up to 100%) of NHEJ-mediated gene knockout [11, 12].
We recently reported the cloning-free CRISPR/Cas sys-
tem, which is based on the Cas9 protein and chemically
synthesized dual-RNAs (crispr RNA [crRNA] and trans-
activating crRNA [tracrRNA]) instead of broadly used
single-guide RNA (sgRNA, a chimeric molecule of crRNA
and tracrRNA), facilitates HR-mediated gene cassette
knock-in in mice by up to 50% [8]. The technological devel-
opment of CRISPR/Cas-mediated gene cassette knock-in in
mice is just beginning, and much improvement is required.
A major alternative pathway for DSB repair, named
microhomology-mediated end joining (MMEJ), joins the
ends of DSBs by utilizing microhomology for the align-
ment of broken ends, leading to deletions at the site of
the DSBs [17]. Interestingly, the microhomologies were
frequently found in the majority of repaired sites of the
DSBs induced by CRISPR/Cas in mice [18] and human
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cells (more than half of the deletions [19]). Taking ad-
vantage of the high frequency of MMEJ, we recently de-
veloped the highly efficient and convenient CRISPR/Cas
or transcription activator-like effector nuclease (TALEN)-
based precise integration into the target chromosome
(PITCh) system that harnesses MMEJ to knock-in a gene
cassette into target genomic loci with extremely short
(≤40 bp) microhomologies in cultured cells [20–22], silk-
worms [20], frogs [20], and zebrafish [23]. In addition to its
high efficiency, the PITCh system has the potential to omit
the laborious steps of constructing a targeting vector for
gene cassette knock-in by the use of microhomologies. The
PITCh system may be a key technology for feasible, large-
scale, knock-in projects [14] to generate thousands of mice
expressing enhanced green fluorescent protein (EGFP) or
Cre recombinase under the control of an endogenous pro-
moter, similar to the gene expression nervous system atlas
(GENSAT) project for bacterial artificial chromosome
transgenic mice [13]; however, its validity in mammalian
organisms has not been examined. Here, we show the effi-
cient and highly convenient PITCh-based knock-in strategy
in mice by the combination of an MMEJ-directed simplified
donor vector, overexpression of the MMEJ-enhancing
factor, and the cloning-free CRISPR/Cas system.
Results
Generation of knock-in mice carrying a gene cassette by
the PITCh system
To test the PITCh system in mouse zygotes, we chose the
Actb locus [24, 25] where we previously knocked-in a 2.5-
kb gene cassette by the cloning-free CRISPR/Cas system
with a conventional targeting vector containing 2-kb hom-
ology arms [8]. In the present study, we knocked-in a 5-kb
TetO-FLEX-hM3Dq/mCherry gene cassette (TetO oper-
ator [tetO] sequences followed by inverted Gq-coupled
human M3 muscarinic DREADD (designer receptors ex-
clusively activated by designer drug, hM3Dq)/mCherry
flanked by two pairs of loxP and loxP2722 [FLEX switch])
to the Actb locus (Fig. 1a) [1, 8, 15, 26]. Since linearization
of the donor is required for gene cassette knock-in by the
PITCh system, we designed a synthetic guide RNA se-
quence (gRNA-s1) as the universal guide RNA that shares
no sequence homology with the genomic DNA of several
mammalian species, including human and mouse [21].
We constructed PITCh-directed donor vectors (PITCh-
donor) [21] containing a 5-kb TetO-FLEX-hM3Dq/
mCherry cassette flanked by 40-bp left and right micro-
homologies corresponding to 800 bp downstream of the
Actb polyA signal and gRNA-s1 crRNA target sequences
(Fig. 1a). The PITCh donor was efficiently digested by in
vitro digestion assay (IDA) with gRNA-s1 crRNA,
tracrRNA, and Cas9 protein (Additional file 1: Figure S1).
We then injected the circular PITCh donor together
with chemically synthesized Actb and gRNA-s1 crRNAs
and tracrRNA, and Cas9 protein into one-cell-stage
mouse zygotes (Fig. 1b) [8]. We obtained 25 newborns,
and screened their tail genomic DNA by PCR with three
different primer sets (Fig. 1a) to identify knock-in mice
(Fig. 1c, d and Additional file 1: Figure S2). We found
three knock-in mice defined by triple PCR positive car-
rying a TetO-FLEX-hM3Dq/mCherry cassette at the
Actb locus (Fig. 1c, d and Additional file 1: Figure S2).
Knock-in efficiency was 12% (Fig. 1d). We also found
two partial knock-in mice defined by double PCR posi-
tive for LF + LR and IF + IR carrying a part of the cas-
sette at the Actb locus (mice #10 and #18 in Additional
file 1: Figures S2). Next, we sequenced the PCR products
of the left and right boundaries between Actb and the
TetO-FLEX-hM3Dq/mCherry cassette and found the
precise knock-in of the cassette we designed (Fig. 1e).
Although left boundaries were precisely knocked-in in
two partial knock-in mice, we could not determine their
right boundaries (data not shown). We also sequenced
the PCR products of non-knock-in Actb alleles amplified
with LF and RR primers. These alleles were modified by
NHEJ in 92% of the newborn mice (Fig. 1d and
Additional file 1: Figure S3). Collectively, the knock-in
mice carrying a gene cassette could be generated by
the PITCh system in combination with cloning-free
CRISPR/Cas system. However, its efficiency (12%, Fig. 1d)
was much lower than that of our previous study (45.5%,
[8]), which was accomplished by the combination of a
conventional targeting vector with long homology arms
and the cloning-free CRISPR/Cas system, although the
length of knock-in cassette in this study was larger than
that of previous report (5 kb vs. 2.5 kb).
Genetic screening of MMEJ enhancer
To enhance the efficiency of the MMEJ-mediated gene
cassette knock-in, we conducted genetic screening to
identify genes that enhance MMEJ. We constructed a
fluorescent reporter system to detect MMEJ-mediated
repair of DSBs, similar to the previous report [27]. The
reporter plasmid expressing inactive (out-of-frame)
EGFP was split by a CRISPR target sequence containing
two tandem microhomologies under the control of the
CMV promoter (Fig. 2a). When the DSBs in the reporter
plasmid induced by CRISPR are repaired through MMEJ
between two microhomologies, functional in-frame
EGFP is reconstituted and EGFP fluorescence is recov-
ered (Fig. 2a). We chose 13 candidate genes from among
those involved in DSB repair pathways (Exonuclease 1
[Exo1], DNA Ligase 3 [Lig3], Poly (ADP-Ribose) Polymer-
ase 1 [PARP1], Nijmegen Breakage Syndrome protein 1
[NBS1], Flap structure-specific Endonuclease 1 [FEN1],
Bloom syndrome RecQ like helicase [BLM], Meiotic Re-
combination 11A [MRE11A], RAD51, RAD52, Three
Prime Repair Exonuclease 2 [TREX2], dominant-negative
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DNA ligase 4 [DN-Lig4], and dominant-negative Ku70
[DN-Ku70]) and introduced plasmids expressing these
cDNAs together with three plasmids; the MMEJ-
monitoring reporter, CRISPR/Cas vector targeting the
reporter, and mCherry-expressing vector (Fig. 2b) into
HEK293T cells. Of these, we found overexpression of
MMEJ-related genes and dominant-negative mutants in-
creased the number of EGFP-positive cells (Fig. 2c, d).
Especially, MMEJ efficiency by Exo1 overexpression in-
creased more than 2.5-fold compared to that of the mock
overexpression quantified by imaging analysis (Fig. 2d).
The overexpression of TREX2, RAD51, or RAD52 did not
increase the number of EGFP-positive cells. Conversely,
significant reduction of EGFP-positive cells was observed
with RAD52 overexpression compared to that of mock
overexpression, consistent with the involvement of this
gene in the DSB repair pathway through homologous
recombination [28]. These results suggest that overexpres-
sion of MMEJ factors, including Exo1, and dominant-
negative NHEJ factors specifically enhanced MMEJ for
DSB repair in human cells. Among these, we focused
on Exo1 in this study, because Exo1 was reported to
increase the mutation frequency of TALEN in mam-
malian cells and zygotes by potentially acting as an
MMEJ enhancer [29].
Exo1 enhances PITCh-mediated gene cassette knock-in in
human cells
Next, we tested whether Exo1 enhances the efficiency of
PITCh-mediated gene cassette knock-in in an endogen-
ous target locus in human cells. We constructed the
PITCh-donor targeting human fibrillarin (FBL) gene, a
component of a nucleolar small nuclear ribonucleopro-
tein, containing a 1.4-kb mNeonGreen-2A-puromycin
cassette [20, 21], although puromycin selection was not
used in this study. This cassette was flanked by 40-bp
left and right microhomologies corresponding to the last
coding exon of the FBL and gRNA-s1 crRNA target se-
quences (hereafter, PITCh(gRNA-s1)-FBL) (Fig. 3a). The
in-frame C-terminal fusion of FBL with the cassette pro-
duces the mNeonGreen fluorescence in the nucleolar.
We introduced the PITCh(gRNA-s1)-FBL donor and the
all-in-one CRISPR/Cas plasmid [30] expressing two
sgRNAs targeting endogenous FBL [20] and gRNA-s1,
and the Cas9 protein, together with plasmids expressing
Exo1 or MRE11A cDNAs in HEK293T cells (Fig. 3b).
Fluorescence-activated cell sorting (FACS) analysis re-
vealed the knock-in efficiency of the mNeonGreen cassette
to the endogenous FBL locus with Exo1 overexpression in-
creased 30% compared to that with mock or MRE11A
overexpression without drug selection (Fig. 3c and
Additional file 1: Figure S4). The knock-in-enhancing ef-
fect of Exo1 was also confirmed by imaging analysis using
laser-scanning microscopy (LSM). For imaging analysis,
mCherry-expressing vectors were co-transfected with the
above-described vectors, and the areas of mNeonGreen-
and mCherry-positive cells were calculated (Additional file
1: Figure S5). Consistent with the results of the FACS
analysis, Exo1 increased the percentages of mNeonGreen-
positive cells in mCherry-positive cells by 50% (approxi-
mately 20 vs. 30% for mock vs. Exo1 overexpression,
Fig. 3d). A magnified view of the LSM images confirmed
nucleolar localization of the green fluorescence foci, sug-
gesting that the mNeonGreen-positive cells could be con-
sidered as the correctly knocked-in cells (Fig. 3e and
Additional file 1: Figure S6). We further confirmed correct
gene knock-in in Exo1-overexpressed cells by DNA se-
quencing of 5’ and 3’ junctions (Fig. 3f). Correct knock-in
junctions without any mutations were frequently found at
both 5’ and 3’ junctions, and their frequencies are compar-
able with those using a donor with 20-bp microhomology
without Exo1 overexpression reported previously [21]
(46.7 and 93.8% with Exo1, 80 and 50% without Exo1). In
addition, we performed Western blotting and toxicity ana-
lysis to confirm the effectiveness and safeness of Exo1
overexpression. The results suggested that protein level of
Exo1 was increased by overexpression and it did not affect
cell viability (Additional file 1: Figure S7 and S8).
To confirm the knock-in-enhancing effect of Exo1, we
knocked-in the same gene cassette at another gene locus in
another cell line. We aimed to target human Actb (hACTB)
gene in HeLa cells (Fig. 4a). The knock-in efficiency with
Exo1 overexpression slightly increased compared to that
without Exo1 (Fig. 4b). LSM observation revealed that
fluorescent cells showed cytoplasmic localization and per-
ipheral accumulation (Fig. 4c). The correct knock-in was
(See figure on previous page.)
Fig. 1 Generation of knock-in mice carrying a gene cassette by the PITCh system. a Targeting strategy for the generation of Actb-TetO-FLEX-
hM3Dq/mCherry knock-in mice by the PITCh system. Purple highlights indicate microhomologies between endogenous Actb locus and PITCh-
donor. Blue characters indicate CRISPR target sequences. Red characters indicate protospacer adjacent motif (PAM) sequences. Yellow lightnings
indicate DSB sites. b Schematic diagram of pronuclear injection of Cas9 protein, Actb and gRNA-s1 crRNAs, tracrRNA and PITCh-donor. The red,
purple, and blue boxes indicate the insert, Actb microhomologies, and gRNA-s1 target sequences, respectively. c PCR screenings of knock-in
newborns. d Summary of Actb-TetO-FLEX-hM3Dq/mCherry knock-in mouse production by the PITCh system. e Sequences of boundaries between
Actb and TetO-FLEX- hM3Dq/mCherry cassette. Blue characters indicate microhomologies. IF: internal forward primer, IR: internal reverse primer,
LF: left forward primer, LR: left reverse primer, RF: right forward primer, RR: right reverse primer, MH: microhomology, M: molecular marker, WT:
wildtype, KI: knock-in, WPRE: woodchuck hepatitis virus posttranscriptional regulatory element, pA: polyA, and KI/+: tail genomic DNA of F1
heterozygous knock-in pup derived from #13 (KI#2) F0 knock-in mouse
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also confirmed by DNA sequencing analysis (Fig. 4d, e).
Without Exo1 overexpression, the percentages of precise
knock-in were 47.4 and 71.4% at the 5’ and 3’ junctions, re-
spectively (Fig. 4d). With Exo1 overexpression, the percent-
ages of precise knock-in were 58.8 and 100% at the 5’ and
3’ junctions, respectively (Fig. 4e). From these direct com-
parison analysis, it was suggested that Exo1 overexpression
might result in not only higher efficiency but also higher
accuracy.
It has been well known that functional hACTB protein
is produced from a single gene; however, there are many
pseudogenes in the human genome [31]. The in silico
prediction of the cleavage sites of sgRNA designed to
knock-in in hACTB locus revealed that there were a lot of
candidate sites in the human genome (Additional file 1:
Table S1). We thus aligned the upstream and downstream
regions of genomic DSB site of the on-target and 14 off-
target sites listed according to the scores calculated by the
COSMID webtool [32] (Fig. 5a). Compared with the re-
sults of sequencing analysis, we found that some base
replacements found in the sequenced alleles seemed to be
derived from off-target integrants (highlighted in blue let-
ters in Figs. 4d and 5a). More interestingly, mismatched
bases near the DSB site were replaced with the donor
sequence, whereas those far from the DSB site were not
replaced, suggesting that possible window of base replace-
ment via MMEJ repair was determined as around 15 bp
each, when the lengths of microhomologies were set as
40 bp (Fig. 5a, b). Collectively, these results suggest
that Exo1 enhances the efficiency, and specificity
when targeted multiple genomic sites, of the PITCh-
mediated gene cassette knock-in in the endogenous
target loci in human cells.
PITCh-mediated gene cassette knock-in in mice with Exo1
We further tested whether Exo1 enhances the efficiency
of PITCh-mediated gene cassette knock-in in the en-
dogenous target locus in mouse zygotes. We injected the
circular PITCh donor with chemically synthesized Actb
and gRNA-s1 crRNA and tracrRNA and the Cas9 pro-
tein with in vitro-transcribed human Exo1 mRNA into
one-cell stage mouse zygotes (Fig. 6a). We obtained 14
newborn mice, of these, five were identified as triple
PCR positive knock-in mice carrying a TetO-FLEX-
hM3Dq/mCherry cassette at the Actb locus (Fig. 6b, c
and Additional file 1: Figure S9). We also found one par-
tial knock-in mouse defined by double PCR positive for
LF + LR and IF + IR carrying a part of the cassette at the
Actb locus (mouse #2 in Fig. 6b). Next, we sequenced
the PCR products of the left and right boundaries be-
tween Actb and the TetO-FLEX-hM3Dq/mCherry cas-
sette. We found the precise knock-in of the cassette at
both boundaries in four out of five knock-in mice
(Fig. 6d). In eKI#2, although the 3’ boundary was pre-
cisely knocked-in as we had designed, we found a re-
sidual partial sequence of gRNA-s1 adjacent to the 5’
microhomology of the gene cassette (Fig. 1a) and a 57-
bp deletion of the endogenous locus, which did not
affect endogenous Actb or exogenous cassette functions
(Fig. 6d). Although left boundary was precisely knocked-
in in one partial knock-in mouse, we could not deter-
mine its right boundary (data not shown). The non-
knock-in Actb alleles were modified by NHEJ in all the
newborn mice (Fig. 6c and Additional file 1: Figure S10).
Taken together, the knock-in efficiency of the gene cas-
sette by the combination of Exo1, PITCh-donor, and
cloning-free CRISPR/Cas was 35.7%, with or without
functionally negligible mutations (Fig. 6c). These results
revealed that increasing tendency of PITCh-mediated
gene cassette knock-in by Exo1 in the endogenous target
locus in mouse zygotes.
We further tested off-target cleavage in the knock-in
mice generated by the cloning-free CRISPR/Cas system-
based PITCh system. We chose five off-target candidate
loci containing up to 3 bp mismatches compared to the
20-bp guide sequence of Actb crRNA [8]. Among five
off-target candidate loci in three knock-in mice without
Exo1 overexpression and five knock-in mice with Exo1
overexpression, we did not find any off-target digestion
(Additional file 1: Figure S11 and Table S2). These
results suggest that PITCh-mediated gene cassette knock-
in in mouse zygotes by the cloning-free CRISPR/Cas
system is highly specific to the on-target locus, and its
specificity is not affected by Exo1 overexpression.
Subsequently, we crossed F0 knock-in mice with a
wild-type mouse to investigate germline transmission of
the knock-in alleles to the F1 generation. We tested seven
knock-in mice, and found successful germline transmis-
sion of the knock-in allele in F1 progeny (Additional file 1:
Figure S12 and Table S3). The efficiencies of germline
transmission were 50% or higher in five out of seven F0
knock-in mice, suggesting that these F0 mice were hetero-
zygous knock-in mice. In contrast, two (KI#2 and eKI#1)
showed 33.3% efficiencies of germline transmission. These
(See figure on previous page.)
Fig. 2 Screening of MMEJ-enhancing factors using a fluorescence reporter assay. a Schematic diagram of MMEJ-dependent EGFP recovery.
Green letters indicate chromophore sequence. Black line indicates CRISPR target sequence. Black box indicates protospacer adjacent motif (PAM)
sequence. Black triangles indicate DSB site. MH, microhomology. CMV, cytomegalovirus promoter. b Schematic diagram of HEK293T-based
reporter assay, followed by imaging analysis. c Fluorescence microscopy images of transfected cells. Bars, 500 μm. d Relative frequencies of MMEJ
repair, fold to mock overexpression. The MMEJ frequencies were calculated by imaging analysis. Data are expressed as means ± SEM (n = 4)
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results suggest that germline mosaicism was occurred in
some knock-in mice; however, its frequency was low.
Compared to the newborn rates of our previous work
using conventional targeting vector (17%, [8]), it was low
in PITCh system (5.4% without Exo1 and 2.5% with
Exo1). We hypothesized that linearization of circular
PITCh donor may partially explain this. We injected the
PCR-amplified linear PITCh donor without vector back-
bone together with chemically synthesized Actb and
gRNA-s1 crRNAs and tracrRNA, and Cas9 protein into
one-cell-stage mouse zygotes in the absence of Exo1
(Additional file 1: Figure S13a), and obtained only
one newborn from the transfer of 191 embryos (0.5%,
Additional file 1: Figure S13b). Next, we injected PCR-
amplified linear PITCh donor at reduced doses, Actb
crRNA, tracrRNA, and Cas9 protein (Additional file 1:
Figure S13a). We obtained one newborn from the transfer
of 71 embryos with 5 ng/μl linear PITCh donor (1.4%,
Additional file 1: Figure S13b). When we further reduced
the dose of linear PITCh donor with 1.5 ng/μl, the new-
born rate was improved to 4.2% (5 newborns from 119
embryo transfer) (Additional file 1: Figure S13b). These
results suggest that linear donor DNA itself is detrimental
to the embryo development, rather than Exo1, and the
birth rate can be improved in the donor DNA dose
dependent manner.
We finally tested whether modified injection protocol
with reduced donor DNA concentration could produce
knock-in mice by enhanced PITCh system. We chose
the Col12a1 gene and designed a PITCh donor to
knock-in the floxed allele for exon 2 substitution as well
as a pair of crRNA targeting the flanking introns to ex-
cise the target exon (Fig. 7a) because global Col12a1-
knockout mice showed severe skeletal abnormalities and
perinatal lethality [33]. We injected the reduced amount
of circular PITCh donor (5 ng/μl) together with chemically
synthesized Col12a1 and gRNA-s1 crRNAs, tracrRNA,
Exo1 mRNA, and Cas9 protein into one-cell-stage mouse
zygotes (Fig. 7b). We screened nine newborns by HindIII
digestion of genomic PCR products and sequencing, and
identified three as knock-in mice carrying floxed alleles
(Fig. 7c–e, and Additional file 1: Figure S14). Further, we
cloned and sequenced the PCR products, and found the
precise knock-in of a HindIII site and two LoxP sites on
the same alleles in all three knock-in mice as we designed
(Fig. 7f). The precise integration of two LoxP sites on the
same allele was also confirmed by excision of the allele by
Cre recombinase (Fig. 7g), although Col12a1 protein level
was not investigated. The knock-in efficiency of floxed
Col12a1 was 33.3% (Fig. 7e) comparable to that of Actb by
enhanced PITCh system (Fig. 6c). Collectively, the modi-
fied injection protocol is enough to produce the knock-in
mice carrying a floxed allele by enhanced PITCh system
with sufficient efficiency.
Discussion
Although we previously developed an improved CRISPR/
Cas system for HR-mediated gene cassette knock-in in
mice by using chemically synthesized dual-RNAs and
commercially available Cas9 protein [8], constructing tar-
geting vectors containing long homology arms corre-
sponding to every target locus has remained cumbersome
and fundamentally unchanged for 30 years [2]. In this re-
port, we applied the PITCh system for the generation of
knock-in mice, and this resulted in the omission of the la-
borious steps of constructing targeting vectors. Our new
method has major advantages for researchers generating
gene cassette knock-in mice.
First, our method enables extremely convenient and
high-throughput donor vector production. Because the
MMEJ-directed donor vector can easily be prepared by a
single PCR and TA-cloning using primers conjugated
with 40-bp microhomology and gRNA-s1 crRNA target
sequence from any template plasmid containing various
gene cassettes (EGFP, Cre, and any functional gene cas-
settes) [21], the long homology arms, which have to be
amplified from genomic DNA, are no longer required.
Thus, for example, nearly 100 MMEJ-directed donor vec-
tors corresponding to nearly 100 target loci can be pre-
pared by a single PCR reaction in a 96-well plate and
those TA-cloning, enabling a large-scale, high-throughput,
knock-in mouse project [13, 14]. By combining the en-
hanced PITCh system with the cloning-free CRISPR/Cas
system, critical steps are to design primers to PCR amplify
various gene cassettes for 40-bp microhomology arms and
their subsequent cloning. Thus, our new method provides
(See figure on previous page.)
Fig. 3 Enhancement of MMEJ-mediated gene knock-in by Exo1 overexpression at the FBL locus in HEK293T cells. a Schematic diagram of gene
knock-in strategy at the FBL locus in HEK293T cells. Black lines indicate CRISPR target sequences. Black boxes indicate PAM sequences. Black triangles
indicate DSB sites. MH, microhomology. Puro, puromycin resistance gene. b Schematic diagram of gene knock-in in HEK293T cells, followed by FACS
analysis. c Relative frequencies of gene knock-in, fold to mock overexpression. The knock-in frequencies were calculated by FACS analysis (Additional
file 1: Figure S4). Data are expressed as means ± SEM (n = 3). Statistical significance was determined by Student’s t-test. *P < 0.05. d The percentages
of mNeonGreen-positive cell areas in mCherry-positive cell areas, calculated by imaging analysis (Additional file 1: Figure S5). Data are expressed as
means ± SEM (n = 3). Statistical significance was determined by Student’s t-test. *P < 0.05. e Confocal laser scanning microscopy images of transfected
cells. The knocked-in cells showed nucleolar localization of mNeonGreen fluorescence. Bars, 30 μm. f DNA sequencing analysis of bacterially cloned PCR
products of 5’ and 3’ junctions amplified from the cells knocked-in with Exo1. The intended knocked-in sequence is shown at the top of each set of
sequences. Blue letters indicate the microhomologies. Red letters indicate insertions
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Fig. 5 Potential window of MMEJ-dependent base replacement revealed by sequence alignment of on- and off-target knock-ins. a Sequence
alignment of upstream and downstream regions of the DSB site. OT1–OT14 represents off-target sites, related to Additional file 1: Table S1. Roman
numbers shown at the right side of each set of sequences indicate the allele types, related to Fig. 4d, e and Additional file 1: Figure S15, S16 and
Table S1. Black triangles indicate the DSB site. Black boxes indicate the CRISPR target sequence. Red and blue underlines indicate the left and right
microhomologies, respectively. Black underlines indicate mutated sequences found in sequenced knock-in junctions. Blue letters indicate the
polymorphisms found in sequenced knock-in junctions, related to Fig. 4d, e. Red letters indicate the mutations not found in the sequenced
knock-in junctions. Asterisks indicate positions with complete base conservation among on- and off-target sites. The positions of bases replaced
and not replaced with the donor sequence were masked in red and blue, respectively. The upstream sequences of OT2, OT3, OT4, OT5, OT7, and
OT8 and the downstream sequences of OT5, OT6, and OT8 were identical, respectively (Additional file 1: Figure S17). b Schematic representation
of potential MMEJ window. Red and blue boxes indicate the left and right microhomologies, respectively
(See figure on previous page.)
Fig. 4 MMEJ-mediated gene knock-in at the hACTB locus in HeLa cells. a Schematic diagram of gene knock-in strategy at the hACTB locus in HeLa
cells. Black lines indicate CRISPR target sequences. Black boxes indicate PAM sequences. Black triangles indicate DSB sites. MH, microhomology.
Puro, puromycin resistance gene. b Relative frequencies of gene knock-in, fold to mock overexpression. The knock-in frequencies were calculated
by FACS analysis, similar to Fig. 3b, except that mCherry was used to normalize the transfection efficiency. Data are expressed as means ± SEM
(n = 3). Statistical significance was determined by Student’s t-test. *P < 0.05. c Confocal laser scanning microscopy images of transfected cells. The
knocked-in cells showed cytoplasmic localization and peripheral accumulation of mNeonGreen fluorescence. Bars, 30 μm. d, e DNA sequencing
analysis of bacterially cloned PCR products of 5’ and 3’ junctions amplified from the cells knocked-in without Exo1 (d) and with Exo1 (e). The
intended knocked-in sequence is shown at the top of each set of sequences. Blue bars indicate the microhomologies. Red letters indicate
mutated bases including insertions, deletions, and substitutions. Blue letters indicate polymorphisms found on the off-target genomic sites,
related to Fig. 5a. Roman numbers shown at the left side of each set of sequences indicate the allele types, related to Fig. 5a and Additional
file 1: Figure S15, S16 and Table S1. Statistical significance was determined by chi-square test. *P < 0.05. ** P < 0.01
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a novel approach to a knock-in gene cassette in mice on
scales of both a small laboratory and a large international
consortium.
Second, the enhanced PITCh system enabled gene cas-
sette knock-in mouse generation. We successfully gener-
ated knock-in mice carrying a 5-kb gene cassette by the
original PITCh system [20, 21] in combination with the
cloning-free CRISPR/Cas system with about 10% effi-
ciency. Its efficiency was acceptable and comparable to
previous reports using an HR-based conventional target-
ing vector with long homology arms [6, 10]. We per-
formed genetic screening to identify an MMEJ enhancer
and found that the co-delivery of Exo1 enhanced knock-
in efficiency in human cells. We showed that the knock-
in efficiency of a 5-kb gene cassette in mice was 30% by
the combination of Exo1, the PITCh system, and the
cloning-free CRISPR/Cas system. We further showed
the validity of the enhanced PITCh system in mice in
another genomic locus by knocking in floxed alleles.
These efficiencies are sufficient for conventional use, and
thus, several knock-in newborn mice can be obtained
from small-scale embryonic manipulation, leading to
flexible, high-throughput and high-variety, low-volume
mouse genetics.
Despite the use of short microhomology (40 bp) in the
PITCh system, the junctions between the endogenous
locus and the insert were precisely integrated in the ma-
jority of the knock-in mice (21 out of 22 boundaries
from 11 knock-in mice). We also found a short deletion
of the endogenous locus at the 5’ junction in one knock-
Fig. 6 Generation of gene cassette knock-in mice by the enhanced PITCh system. a Schematic diagram of pronuclear injection of Cas9 protein, Actb
and gRNA-s1 crRNAs, tracrRNA, PITCh-donor, and Exo1 mRNA. b PCR screenings of knock-in newborns. c Summary of Actb-TetO-FLEX-hM3Dq/mCherry
knock-in mouse production by the enhanced PITCh system. d Sequences of boundaries between Actb and TetO-FLEX- hM3Dq/mCherry cassette. Blue
and red characters indicate microhomologies and partial crRNA(gRNA-s1) target sequence, respectively. IF: internal forward primer, IR: internal reverse
primer, LF: left forward primer, LR: left reverse primer, RF: right forward primer, RR: right reverse primer, MH: microhomology, M: molecular marker, WT:
wildtype, KI: knock-in, and KI/+: tail genomic DNA of F1 heterozygous knock-in pup derived from #13 (KI#2) F0 knock-in mouse
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in mouse treated with Exo1, suggesting NHEJ-mediated
repair occurred between the deleted genome and the
digested donor end. Although the imprecise repair
around the targeted integration locus did not affect en-
dogenous gene or exogenous cassette functions when
the introns or intergenic regions were targeted, further
technological improvements are required for precise tar-
geting of the coding regions to fuse the gene cassettes
with endogenous gene products. In addition, we found a
few partial knock-in mice defined by double PCR posi-
tive for LF + LR and IF + IR (e.g. mice #10 and #18 in
Additional file 1: Figures S2 and mouse #2 in Fig. 6b) in
the presence or absence of Exo1. The whole plasmid in-
tegration by insufficient digestion of right boundary of
the PITCh-donor or deletion of primer-binding site in
mouse genome or PITCh-donor caused by DNA end re-
section might result in failure of right boundary amplifi-
cation. Nevertheless, the enhanced PITCh system can
generate knock-in mice with sufficient efficiency, and
the majority of these mice had precise integration of the
gene cassette to the endogenous locus, providing oppor-
tunities to select precisely targeted knock-in mice.
We found Exo1 as an MMEJ enhancer both in human
cells and mouse zygotes. Exo1 is a major 5’–3’ exonucle-
ase, which is critical for the end resection of DSBs to
promote MMEJ [17]. The mutation and overexpression
of Exo1 in yeasts are reported to reduce and increase
MMEJ, respectively [34, 35]. Consistent with this view,
we recently reported that the overexpression of Exo1 in-
creased knockout efficiency possibly through increased
MMEJ in rat zygotes [29]. Thus, in the enhanced PITCh
system, Exo1 may act as the MMEJ enhancer by resec-
tion of the DSB ends of both the endogenous locus and
the donor vector, promoting their alignment using
microhomology. We also showed that various MMEJ-
related genes and dominant-negative mutants of NHEJ
factors enabled to enhance MMEJ. The enhancer effect
of these genes in gene knock-in should be examined in
the future study. On the other hand, additional three
genes (TREX2, RAD51, and RAD52) involved in the re-
pair pathway of DSBs did not enhance MMEJ. TREX2 is
also a DNA end-processing enzyme, which reportedly
enhances gene disruption when overexpressed with site-
specific nucleases [36]. However, it slightly decreased
MMEJ frequency, suggesting that it is involved in other
DSB repair pathways rather than in the MMEJ pathway.
Similarly, RAD51 and RAD52, known as HR-specific fac-
tors [28], also decreased the MMEJ frequency.
We additionally investigated whether mismatched
bases in microhomologies can be replaced with the
donor sequence during the PITCh knock-in, by simul-
taneously targeting the hACTB locus and other pseudo-
genes. Although there might be an amplification bias of
5’ and 3’ junctions depending on the sequence variations
between primers and target sites (Additional file 1:
Figure S15), we found two types of off-target knock-in
alleles in 5’ junction and another two types in 3’ junction.
The sequence comparison between genomic sequences
and sequenced alleles revealed that the base-replacing
window was around 15 bp. This parameter might be
changed when the different length of microhomology
is used or different site-specific nucleases such as
TALENs are used, but this finding would be import-
ant to design both the target site and microhomolo-
gies for PITCh knock-in, especially when multiple
genomic loci are simultaneously targeted.
The injection of linear PCR donors was enough to re-
duce the newborn mouse rates in a dose dependent
manner. Consistent with our data, Miura et al. also re-
ported that injection of linear double strand DNA donor
strongly reduce the newborn mouse rates [37]. These re-
sults suggest that the low birth rate of newborn mice in
PITCh system is mainly caused by toxicity of linear
donor DNA generated by CRISPR-mediated in situ di-
gestion. The survival rate can be improved by the reduc-
tion of PITCh donor dose. We showed this modified
protocol could also produce knock-in mice without re-
duction of its efficiency. Although transfection of the
various doses of Exo1 expressing plasmids to HEK293T
cell did not affected their survival, its overexpression in
mouse zygotes reduced the newborn rate. A recent re-
port in the human cell line showed that overexpression
of TREX2, an end-processing enzyme, increased both
on- and off-target mutation rates [38], whereas other
showed opposite results [36]. This suggests the possibil-
ity that the overexpression of Exo1 may also increase
(See figure on previous page.)
Fig. 7 Generation of floxed mice by the enhanced PITCh system. a Targeting strategy for the generation of floxCol12a1 mice by the enhanced
PITCh system. Purple highlights indicate microhomologies between endogenous Col12a1 locus and PITCh-donor. Blue characters indicate CRISPR
target sequences. Red characters indicate protospacer adjacent motif (PAM) sequences. Yellow lightnings indicate DSB sites. b Schematic diagram
of pronuclear injection of Cas9 protein, Col12a1-left, -right, and gRNA-s1 crRNAs, tracrRNA, PITCh-donor, and Exo1 mRNA. The red, purple, and
blue boxes indicate the insert, Col12a1 microhomologies, and gRNA-s1 target sequences, respectively. c PCR screenings of newborns. d PCR-RFLP
(restriction fragment length polymorphism) screenings of floxed newborn mice. e Summary of floxCol12a1 mouse production by the enhanced
PITCh system. f Sequences of boundaries between Col12a1 and LoxPs. Blue, green, and red characters indicate microhomologies, HindIII sites, and
LoxPs, respectively. g in vitro Cre-recombination assay. Cloned PCR products of flox alleles from three floxCol12a1 mice and genomic PCR of wildtype
were incubated with or without Cre-recombinase. LF: left forward primer, RR: right reverse primer, MH: microhomology, M: molecular marker, and
WT: wildtype
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off-target mutation rate, leading to the reduction of new-
born mouse rate, and thus, the careful guide RNA design
is also essential.
The development of small molecules that activate Exo1
may be useful for improvement of knock-in efficiency.
Scr7, a small compound inhibitor of DNA ligase IV, which
is responsible for NHEJ, was recently developed [39] and
harnessed to improve the efficiency of HR-mediated
knock-in of single nucleotide substitutions and small tags
in mice [12, 40] and human cells [41] by suppressing
NHEJ. Further, the two small compounds (L755507 and
Brefeldin A) were also identified as enhancers for HR by
chemical screening using the fluorescent HR reporter sys-
tem [42]. Similarly, RS-1, a stimulator of Rad51 [43], is
shown to enhance knock-in of long inserts in cellular
knock-in screening [44] and rabbits [45]. Thus, by utilizing
the fluorescent reporter system to detect MMEJ-mediated
repair of DSBs, which we used herein, the small com-
pounds that enhance MMEJ and PITCh-mediated gene
cassette knock-in could be identified.
Conclusions
We developed a convenient HR-independent method for
one-step generation of knock-in human cells and mice
carrying gene cassettes and floxed allele without long
homology arms by enhanced PITCh system.
Methods
Plasmid construction for human cell experiments
The CRISPR/Cas9 vector expressing Cas9 nuclease and
an sgRNA targeting EGFP reporter vector was con-
structed using pX330 vector (Addgene Plasmid #42230)
according to the previously described protocol [46].
The all-in-one CRISPR/Cas9 vector expressing Cas9 nu-
clease and two sgRNAs targeting the FBL or hACTB gene
and the donor vector was constructed using the
Multiplex CRISPR/Cas9 Assembly System Kit (Addgene
Kit #1000000055) as described previously [30]. The oligo-
nucleotide sequences for sgRNA templates were listed in
Additional file 1: Table S4.
The overexpression vectors were constructed using an
RT-PCR and In-Fusion HD Cloning Kit. Briefly, the full
coding sequences for the 14 genes listed in Fig. 2d were
amplified using an RT-PCR from total RNAs extracted
from HEK293T cells. The amplified cDNAs were
cloned into ptCMV-136/63-VR-NG vector (Addgene
Plasmid #50700) [47], replacing the transcription activator-
like effector nuclease-coding sequence with each cDNA.
The sequences of primers used to construct the overexpres-
sion vectors were listed in Additional file 1: Table S4.
The EGFP reporter vector for monitoring MMEJ
frequency was constructed using a PCR and In-Fusion
HD Cloning Kit (Takara). PITCh(gRNA-s1)-FBL and
PITCh(gRNA-s1)-hACTB donor plasmids were constructed
using a PCR and TA-cloning with DynaExpress TA PCR
Cloning Kit (pTAC-2) (BioDynamics Laboratory Inc.) or
TArget Clone -Plus- (Toyobo). The full plasmid sequences
of EGFP reporter vector, PITCh(gRNA-s1)-FBL donor vec-
tor, and PITCh(gRNA-s1)-hACTB donor vector are shown
in Additional file 1: Figure S17.
Cell culture and transfection
HEK293T and HeLa cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal
bovine serum. Lipofectamine LTX (Life Technologies)
and Opti-MEM (Life Technologies) were used to trans-
fect plasmids, according to the manufacturer’s instruc-
tions. Plasmid concentrations, cell numbers, and dishes
used were as follows: for the MMEJ-monitoring reporter
assay, 100 ng each for all the plasmid vectors (EGFP re-
porter vector, CRISPR/Cas vector, mCherry vector, and
each overexpression vector) into 6 × 104 HEK293T cells
using a 96-well plate; for the FACS and DNA sequencing
analyses and the imaging quantification using LSM of FBL
knocked-in cells, 100 ng each for all the plasmid vectors
(PITCh donor vector, CRISPR/Cas vector, and mock,
Exo1, or MRE11A vector with or without mCherry vector)
into 5.0 × 104 HEK293T cells using a 12-well plate; for the
fluorescence observation of FBL knocked-in cells, 50 ng
each for all the plasmid vectors (PITCh donor vector,
CRISPR/Cas vector, mock or Exo1 vector, and mCherry
vector) into 3 × 104 HEK293T cells using a 96-well plate;
for gene knock-in at the FBL locus and co-transfection of
FBL-mCherry fusion gene, 100 ng each for all the plasmid
vectors (PITCh donor vector, CRISPR/Cas vector, and
FBL-mCherry vector) into 2.5 × 104 HEK293T cells using a
12-well plate; for the FACS analysis of hACTB knocked-in
cells, 100 ng each for all the plasmid vectors (PITCh
donor vector, CRISPR/Cas vector, mCherry vector, mock
or Exo1 vector, and the vector expressing puromycin re-
sistance gene) into 2 × 105 HeLa cells using a 12-well
plate; for the DNA sequencing and fluorescence observa-
tion of hACTB knocked-in cells, 8.3–50 ng each for all the
plasmid vectors (PITCh donor vector, CRISPR/Cas vector,
mCherry vector, mock or Exo1 vector) into 3 × 104 HeLa
cells using a 96-well plate; for Western blotting analysis,
2 μg for mock or Exo1 vector into 5 × 104 HEK293T cells
using a 6-well plate; for toxicity analysis, 1, 3.5, 12.2, 42.9,
and 150 ng each for mock or Exo1 vectors, or 150 ng for
zinc-finger nuclease (ZFN) vector, pSTL-ZFA36 [48], and
150 ng for mCherry vector into 6 × 104 HEK293T cells
using a 96-well plate. After transfection, cells were cultured
in the growth medium described above for 1 day (reporter
assays), 3 days (knock-in experiments and Western blot-
ting), or 2 or 5 days (toxicity analysis), with or without
transferring the cells to a larger culture plate. For the FACS
analysis of hACTB knocked-in cells, puromycin selection
was conducted during 24–72 h post-transfection.
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FACS analysis
Cells were collected, suspended in PBS, and filtered with
a Flowmi Tip Strainer (Bel-Art Products). The number
of cells with green (mNeonGreen) and red (mCherry)
fluorescence, where needed, was counted using a BD
FACS Calibur 4A (BD Biosciences) with a 488-nm laser
and the corresponding fluorescence filters. A total of
10,000 cells were recorded for each sample. For toxicity
analysis, cell survival rates were determined as the per-
centages of the number of mCherry-positive cells in total
cell counts, as described previously [49].
Fluorescence microscopy
For the reporter assays, fluorescence was observed and
cell images were captured using a fluorescence micro-
scope (Olympus CKX41) directly in the cultured plates.
For the knock-in experiments, cells were moved to
collagen-coated glass-bottom 24-well plates at 72 h
post-transfection, cultured for additional 24 h, and fixed
with 4% paraformaldehyde in PBS. Fluorescence was ob-
served and cell images were captured with a 473-nm and
594-nm lasers using a confocal laser-scanning microscope
(Olympus FV-1000D).
Imaging analysis using the ImageJ software
For the reporter assays, the areas containing red fluores-
cence (mCherry) and green fluorescence (EGFP) were cal-
culated from the captured images using the ImageJ
software (https://imagej.nih.gov/ij/). The MMEJ efficiency
was determined as the percentages of the EGFP-positive
areas in the mCherry-positive areas. For the knock-in ex-
periments, imaging analysis was performed as described
in Additional file 1: Figure S4.
Sequencing analysis for human cell experiments
The 5’ and 3’ knock-in junctions of FBL and hACTB genes
were amplified by PCR using the primers listed in
Additional file 1: Table S4 from the cells collected at 72 h
post-transfection without any antibiotic or fluorescence
selection. Subsequently, the PCR products were bacterially
cloned using the TA-cloning method and sequenced.
Western blotting
Cells were collected and dissolved in sample buffer (final
concentrations: 0.125 M Tris-HCl, pH 6.8, 4% SDS, 20%
glycerol, 10% β-mercaptoethanol, 0.005% bromophenol
blue). Western blotting was performed as previously de-
scribed [50]. Briefly, after denaturation by heating at 95
degree for 10 min, 10 μg of each sample was separated
by 4–20% SDS-PAGE (Bio-Rad) along with a protein
standard ladder (Nippon Genetics). The samples were
then transferred to PVDF membranes. The membranes
were cut and blocked in TBS with 0.1% Tween 20 (TBS-
T) and 5% skim milk for 1 h at room temperature, then
incubated with primary monoclonal antibodies against
Exo1 (1:100, Thermo Scientific, Ab-4, clone 266) and β-
Actin (1:1000, Santa Cruz Biotechnology, sc-47778) in
TBS-T containing 1% skim milk at 4° overnight. Next, the
membranes were washed, incubated with HRP-conjugated
anti-mouse IgG secondary antibody (1:5000, Jackson
ImmunoResearch Laboratories, 715-035-151) at room
temperature for 1 h, washed, and visualized with Luminata
Forte Western HRP substrate (Millipore). Gel images were
taken every 1 min for 20 min using Image Lab software
(Bio-Rad). Band intensities of gel images within linear sig-
nal range were quantified using Image Lab software and
normalized with band intensities of β-Actin.
Animal experiments
All research and animal care procedures were approved
by the Tokyo Medical and Dental University Animal
Care and Use Committee. Mice were housed in groups
of 3-5 animals per cage and maintained on a regular
12 h light/dark cycle (8:00–20:00 light period) at a con-
stant 25 °C. Food and water were available ad libitum.
Targeting vector for mouse experiments
Actb-TetO-FLEX-hM3Dq/mCherry PITCh-donor: TetO-
FLEX-hM3Dq/mCherry cassette was PCR-amplified
from an original plasmid with PrimeSTAR GXL DNA
Polymerase (Takara) and primers conjugated with Actb
microhomologies and gRNA-s1 crRNA target sequences
(Fig. 1a), or with Actb microhomologies (Additional file
1: Figure S13). PCR products were directly used as linear
PITCh donors (Additional file 1: Figure S13). Then, PCR
products were cloned into plasmids using Mighty TA-
cloning Kit (Takara). The PCR products were also
inserted into plasmids using In-Fusion HD Cloning Kit
(Takara), in some cases.
floxCol12a1 PITCh-donor: The genomic region contain-
ing exon 2 of Col12a1 was PCR-amplified as described
above with primers conjugated with LoxPs. Then, second
PCR was performed with primers conjugated with Col12a1
microhomologies and gRNA-s1 crRNA target sequences.
Then, PCR products were cloned into plasmids using
Mighty TA-cloning Kit (Takara).
in vitro mRNA transcription
Exo1 mRNA was in vitro transcribed using mMESSAGE
mMACHINE T7 ULTRA Kit (Life Technologies). Exo1
mRNA was purified with MEGAclear Kit (Life Technolo-
gies) and eluted with Nuclease-free water (Life Technolo-
gies). The quality of mRNA was analyzed by NanoDrop
(Thermo Scientific) and Bioanalyzer (Agilent Technologies).
Cas9 proteins
The recombinant Cas9 proteins were obtained from
Fasmac, New England BioLabs (NEB), and PNA Bio.
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Chemical synthesis of crRNA and tracrRNA
crRNAs and tracrRNA (Additional file 1: Table S4) were
chemically synthesized and purified by high pressure li-
quid chromatography (Fasmac).
in vitro digestion assay
IDAs were performed as previously described [8] with
100 ng of the PITCh-donor vector, gRNA-s1 crRNA,
tracrRNA and the Cas9 protein.
Injection
Injections were performed as previously described [8].
For Actb-TetO-FLEX-hM3Dq/mCherry knock-in mice,
Cas9 proteins, Actb and gRNA-s1 crRNAs, tracrRNA,
and PITCh-donor vectors with or without Exo1 mRNA
(30 ng/μl, 0.61 pmol/μl, 10 ng/μl, and 10 ng/μl, respect-
ively) were injected into pronuclei of one-cell stage
BDF1 zygotes. For linear PCR donor injection, Cas9 pro-
teins, Actb crRNA (and gRNA-s1 crRNA), tracrRNA,
and linear PCR PITCh-donor (1.5, 5, or 10 ng/μl) were
injected. For floxCol12a1 mice, Cas9 proteins, left and
right Col12a1 crRNAs, tracrRNA, and PITCh-donor
vectors with Exo1 mRNA (30 ng/μl, 0.61 pmol/μl,
5 ng/μl, and 10 ng/μl, respectively) were injected into
pronuclei of one-cell stage C57BL/6 J zygotes. After
incubation at 37°, one-cell stage embryos were trans-
ferred into pseudopregnant ICR female mice.
PCR screening
PCR screenings of knock-in mice were performed with
primers listed in Additional file 1: Table S4 as previously
described [8]. PCR products were directly sequenced or
cloned, then sequenced. For floxCol12a1 screening, PCR
products were digested with HindIII (NEB).
in vitro Cre-recombination
200 ng of PCR products of cloned floxCol12a1 alleles
from floxed mice or genomic Col12a1 PCR products of
wildtype mice were incubated with Cre recombinase
(NEB) and analyzed by 2% agarose gel electrophoresis
according to the manufacture’s instruction.
Off-target effects of knock-in mice
The potential off-target candidate loci were analyzed as
previously described [8]. PCR primers were listed in
Additional file 1: Table S4.
Statistical analyses
All data are presented as the mean ± SEM. Statistical
methods were described in the figure legends for each
data set. Statistical significance was set at p < 0.05.
Additional file
Additional file 1: The following additional data are available with the
online version of this paper. Additional data file 1 contains the figures
including IDA analysis of PITCh-donor, PCR screenings of mice, sequencing
of non-knock-in Actb alleles, FACS and LSM analysis of human cells, Exo1
western blotting, Exo1 toxicity analysis, off-target analysis in mice, germline
transmission, linear PCR donor injection, and sequence alignments of hACTB
and its off-target sites, and tables of these results and a list of the oligo
DNAs and RNAs used in this study. (DOCX 14447 kb)
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